Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

Overview of attention for article published in Frontiers in Medicine, October 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 6 X users, with an upper bound of 16,816 followers.

728/ https://t.co/NfumDMEIlA

31 Oct 2021

Reply Repost Favourite

4,394/ France (current smoking rate age 18-75 was 32% in 2018) Of 1,044 hospitalized for SARS-CoV-2 infection, 16% were current smokers https://t.co/TuyT47nULB

31 Oct 2021

Reply Repost Favourite

RT @GendronNico: 💡➡️Intermediate- versus Standard-dose prophylactic anticoagulation 💉🩸in #COVID19 patients in medical ward: a propensity sc…

17 Oct 2021

Reply Repost Favourite

RT @GendronNico: 💡➡️Intermediate- versus Standard-dose prophylactic anticoagulation 💉🩸in #COVID19 patients in medical ward: a propensity sc…

17 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.